Both familial Parkinson's disease mutations accelerate α-synuclein aggregation

被引:623
|
作者
Narhi, L [1 ]
Wood, SJ [1 ]
Steavenson, S [1 ]
Jiang, YJ [1 ]
Wu, GM [1 ]
Anafi, D [1 ]
Kaufman, SA [1 ]
Martin, F [1 ]
Sitney, K [1 ]
Denis, P [1 ]
Louis, JC [1 ]
Wypych, J [1 ]
Biere, AL [1 ]
Citron, M [1 ]
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1074/jbc.274.14.9843
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disorder that is pathologically characterized by the presence of intracytoplasmic Lewy bodies, the major component of which are filaments consisting of alpha-synuclein. Two recently identified point mutations in alpha-synuclein are the only known genetic causes of PD, but their pathogenic mechanism is not understood. Here we show that both wild type and mutant alpha-synuclein form insoluble fibrillar aggregates with antiparallel beta-sheet structure upon incubation at physiological temperature in vitro. Importantly, aggregate formation is accelerated by both PD-linked mutations. Under the experimental conditions, the lag time for the formation of precipitable aggregates is about 280 h for the wild type protein, 180 h for the A30P mutant, and only 100 h for the A53T mutant protein. These data suggest that the formation of alpha-synuclein aggregates could be a critical step in PD pathogenesis, which is accelerated by the PD-linked mutations.
引用
收藏
页码:9843 / 9846
页数:4
相关论文
共 50 条
  • [21] No pathogenic mutations in the β-synuclein gene in Parkinson's disease
    Lincoln, S
    Crook, R
    Chartier-Harlin, MC
    Gwinn-Hardy, K
    Baker, M
    Mouroux, V
    Richard, F
    Becquet, E
    Amouyel, P
    Destée, A
    Hardy, J
    Farrer, M
    [J]. NEUROSCIENCE LETTERS, 1999, 269 (02) : 107 - 109
  • [22] Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
    Li, WX
    West, N
    Colla, E
    Pletnikova, O
    Troncoso, JC
    Marsh, L
    Dawson, TM
    Jäkälä, P
    Hartmann, T
    Price, DL
    Lee, MK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) : 2162 - 2167
  • [23] α-Synuclein locus duplication causes familial Parkinson's disease
    Chartier-Harlin, MC
    Kachergus, J
    Roumier, C
    Amouyel, P
    Farrer, M
    Destee, A
    [J]. MOVEMENT DISORDERS, 2004, 19 : S353 - S353
  • [24] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    [J]. NATURE, 1997, 388 (6639) : 232 - 233
  • [25] α-synuclein locus duplication as a cause of familial Parkinson's disease
    Chartier-Harlin, MC
    Kachergus, J
    Roumier, C
    Mouroux, V
    Douay, X
    Lincoln, S
    Levecque, C
    Larvor, L
    Andrieux, J
    Hulihan, M
    Waucquier, N
    Defebvre, L
    Amouyel, P
    Farrer, M
    Destée, A
    [J]. LANCET, 2004, 364 (9440): : 1167 - 1169
  • [26] Insight into Parkinson's Disease from Yeasts: Combined impact of covalent modifications & familial mutations on α-synuclein
    Ganev, Yoan Petrov
    Thomas, Rosemary
    Roman, Alexandra
    Mwale, Chisomo
    Mountain, Joseph
    Balaram, Ariane
    Marshall, Morgan
    DebBurman, Shubhik
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [27] Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
    Gadhe, Laxmikant
    Sakunthala, Arunima
    Mukherjee, Semanti
    Gahlot, Nitisha
    Bera, Riya
    Sawner, Ajay Singh
    Kadu, Pradeep K.
    Maji, Samir
    [J]. BIOPHYSICAL CHEMISTRY, 2022, 281
  • [28] Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease
    Tatenhorst, Lars
    Eckermann, Katrin
    Dambeck, Vivian
    Fonseca-Ornelas, Luis
    Walle, Hagen
    da Fonseca, Tomas Lopes
    Koch, Jan C.
    Becker, Stefan
    Toenges, Lars
    Baehr, Mathias
    Outeiro, Tiago F.
    Zweckstetter, Markus
    Lingor, Paul
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 39
  • [29] Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease
    Torok, Nora
    Majlath, Zsofia
    Szalardy, Levente
    Vecsei, Laszlo
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (11) : 1281 - 1294
  • [30] α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis
    Mehra, Surabhi
    Sahay, Shruti
    Maji, Samir K.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2019, 1867 (10): : 890 - 908